Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Serge_Saxonov
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:CUSIP |
88025U109
|
| gptkbp:foundedYear |
2012
|
| gptkbp:hasCompany |
10x Genomics, Inc.
|
| gptkbp:headquartersLocation |
gptkb:Pleasanton,_California,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:IPODate |
2019-09-12
|
| gptkbp:ISIN |
US88025U1097
|
| gptkbp:marketCap |
large cap (varies over time)
|
| gptkbp:product |
spatial genomics
Chromium platform Visium platform single cell sequencing |
| gptkbp:sector |
gptkb:insurance
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:TXG
|
| gptkbp:tickerType |
gptkb:stock_market_index
|
| gptkbp:website |
https://www.10xgenomics.com/
|
| gptkbp:bfsParent |
gptkb:10x_Genomics
|
| gptkbp:bfsLayer |
7
|
| http://www.w3.org/2000/01/rdf-schema#label |
NASDAQ: TXG
|